VR Logo

Longboard Pharmaceuticals Inc. (LBPH) download report


Healthcare | Biotechnology & Pharma Research

Longboard Pharmaceuticals Inc. (LBPH) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases.

IPO Date: 12-Mar-2021

Pres, CEO, Sec. & Director: Mr. Kevin R. Lind

Chief Financial Officer: Ms. Brandi L. Roberts CPA, M.B.A.

Listing: NASDAQ: LBPH

Country: United States

Headquarters: La Jolla, CA

Website: https://www.longboardpharma.com

Key Facts

Market cap: $53.54 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-31.70 Mln

Cash: $96.12 Mln

Total Debt: $0.00 Mln

Insider's Holding: 31.85%

Liquidity: Low

52 Week range: $2.84 - 18.50

Shares outstanding: 13,586,000

Stock Performance

Time Period Longboard Pharmaceuticals (LBPH) S&P BSE Sensex S&P Small-Cap 600
YTD-38.52-9.18-18.78
1 month-40.30-4.78-8.00
3 months-43.82-9.66-13.65
1 Year-67.110.81-17.19
3 Years--10.336.10
5 Years--11.345.87
10 Years--11.749.84
As on 01-Jul-2022